NO982100L - Peptid-derivater av Dolastatin 15 og deres anvendelse - Google Patents

Peptid-derivater av Dolastatin 15 og deres anvendelse

Info

Publication number
NO982100L
NO982100L NO982100A NO982100A NO982100L NO 982100 L NO982100 L NO 982100L NO 982100 A NO982100 A NO 982100A NO 982100 A NO982100 A NO 982100A NO 982100 L NO982100 L NO 982100L
Authority
NO
Norway
Prior art keywords
dolastatin
peptide derivatives
new
formula
preparation
Prior art date
Application number
NO982100A
Other languages
English (en)
Norwegian (no)
Other versions
NO982100D0 (no
Inventor
Andreas Kling
Bernd Janssen
Wilhelm Amberg
Andreas Haupt
Kurt Ritter
Ernst Buschmann
Harald Bernard
Stefan Mueller
Thomas Zierke
Teresa Barlozzari
Monika De Arruda
Simon Robinson
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO982100L publication Critical patent/NO982100L/no
Publication of NO982100D0 publication Critical patent/NO982100D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO982100A 1995-11-09 1998-05-08 Peptid-derivater av Dolastatin 15 og deres anvendelse NO982100D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/554,897 US5807984A (en) 1995-11-09 1995-11-09 Oligopeptides, the preparation and use thereof
PCT/EP1996/004709 WO1997017364A1 (fr) 1995-11-09 1996-10-30 Derives peptidiques de dolastatine-15 et utilisation desdits derives

Publications (2)

Publication Number Publication Date
NO982100L true NO982100L (no) 1998-05-08
NO982100D0 NO982100D0 (no) 1998-05-08

Family

ID=24215159

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982100A NO982100D0 (no) 1995-11-09 1998-05-08 Peptid-derivater av Dolastatin 15 og deres anvendelse

Country Status (12)

Country Link
US (1) US5807984A (fr)
EP (1) EP0859786A1 (fr)
JP (1) JPH11515032A (fr)
KR (1) KR19990067460A (fr)
AU (1) AU729333B2 (fr)
BR (1) BR9611383A (fr)
CZ (1) CZ139198A3 (fr)
HU (1) HUP9900089A3 (fr)
MX (1) MX9803662A (fr)
NO (1) NO982100D0 (fr)
WO (1) WO1997017364A1 (fr)
ZA (1) ZA969402B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
ATE293638T1 (de) * 1997-09-24 2005-05-15 Univ Arizona Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung
US6686445B1 (en) 1997-09-24 2004-02-03 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
FR2774989B1 (fr) * 1998-02-18 2000-03-17 Adir Nouveaux cytotoxiques derives de l'oestradiol
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
MX2024002571A (es) 2021-09-03 2024-03-20 Toray Industries Composicion farmaceutica para tratamiento y/o prevencion de cancer.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DK0934950T3 (da) * 1991-08-09 2002-07-29 Teikoku Hormone Mfg Co Ltd Tetrapeptidderivat
CZ292612B6 (cs) * 1992-05-20 2003-11-12 Abbott Gmbh & Co. Kg Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
HUT72067A (en) * 1992-12-16 1996-03-28 Basf Ag Dolostatin analog
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters

Also Published As

Publication number Publication date
BR9611383A (pt) 1999-01-26
WO1997017364A1 (fr) 1997-05-15
KR19990067460A (ko) 1999-08-16
ZA969402B (en) 1998-05-08
AU729333B2 (en) 2001-02-01
HUP9900089A2 (hu) 1999-05-28
US5807984A (en) 1998-09-15
JPH11515032A (ja) 1999-12-21
AU7495796A (en) 1997-05-29
MX9803662A (es) 1998-09-30
EP0859786A1 (fr) 1998-08-26
CZ139198A3 (cs) 1998-09-16
NO982100D0 (no) 1998-05-08
HUP9900089A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
NO965412D0 (no) Nye trombin-inhibitorer, deres fremstilling og bruk
MX9706069A (es) Nuevos inhibidores de la trombina.
MY113237A (en) An agricultural and horticultural disease controller and a method for controlling the diseases
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
NO975710D0 (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO995006L (no) Nye forbindelser
NO990662L (no) Trombin-inhibitorer
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
NO992821L (no) Ketobenzamider som calpain-inhibitorer
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO990667D0 (no) Depeptid-benzamidin som kinogenase-inhibitor
NO982100L (no) Peptid-derivater av Dolastatin 15 og deres anvendelse
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO971625L (no) Nye peptider med immunomodulatoriske effekter
ATE226592T1 (de) Peptide, die metallproteinasen und die tnf- freisetzung hemmen, und ihre therapeutische verwendung
NO980296D0 (no) Forbedrede terapeutiske midler
NO973230L (no) Nye peptider, deres fremstilling og anvendelse
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69528855D1 (de) Pyrazolin-Derivate zur Bekämpfung von Pflanzenkrankheiten
NO982105D0 (no) Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider
NO20004613L (no) FremgangsmÕte for fremstilling av et tetrapeptid
EP0780472A3 (fr) Protéines de stress
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application